ArticleNeuro-oncology advances

Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

Chen Makranz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.